| Livium Ltd (LIT) ORDINARY FULLY PAID |
Industrials |
$17 |
Proposed issue of securities - LIT
|
30 Jul 2026 10:07AM |
$0.009 |
$0.008 |
fallen by
11.11%
|
|
| Livium Ltd (LIT) ORDINARY FULLY PAID |
Industrials |
$17 |
Proposed issue of securities - LIT
|
30 Jul 2026 10:06AM |
$0.009 |
$0.008 |
fallen by
11.11%
|
|
| Livium Ltd (LIT) ORDINARY FULLY PAID |
Industrials |
$17 |
LIT Secures Initial A$1.575m Institutional Investment & SPP
|
30 Jul 2026 10:06AM |
$0.009 |
$0.008 |
fallen by
11.11%
|
|
LIT - Price-sensitive ASX Announcement
Full Release
Key Points
- Livium secures A$1.575 million initial investment from Lind.
- Potential funding capacity up to A$11.75 million.
- Launch of Share Purchase Plan for additional shareholder investment.
- Funding supports battery recycling and working capital.
- Strategic evaluation of financing options undertaken.
- Funding agreements are unsecured and interest-free.
- Focus on operational efficiency and new recycling opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Jayride Group Limited (JAY) ORDINARY FULLY PAID |
Industrials |
$9 |
Director Appointment/Resignation
|
30 Jul 2026 10:04AM |
$0.006 |
$0.006 |
fallen by
0%
|
|
| Actinogen Medical Limited (ACW) ORDINARY FULLY PAID |
Health Care |
$171 |
June 2026 Quarterly activity report & Appendix 4C
|
30 Jul 2026 10:03AM |
$0.039 |
$0.046 |
risen by
17.95%
|
|
ACW - Price-sensitive ASX Announcement
Full Release
Key Points
- Pivotal XanaMIA phase 2b/3 Alzheimer's disease trial on track for final results in November 2026
- 88% of main trial participants continue in open-label extension phase with Xanamem therapy
- Positive scientific advice from European Medicines Agency aligns with US FDA
- New patents received for Xanamem treatment and manufacturing
- June 2026 cash balance of $16.7 million extends runway beyond trial results to mid-2027
- Continued strong enrolment and progress in XanaMIA trial and open-label extension
- Publication of positive anti-depressant activity of Xanamem in the British Journal of Psychiatry
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kinetiko Energy Limited (KKO) ORDINARY FULLY PAID |
Energy |
- |
Proposed issue of securities - KKO
|
30 Jul 2026 10:03AM |
$0.035 |
$0.039 |
risen by
10%
|
|
| Kinetiko Energy Limited (KKO) ORDINARY FULLY PAID |
Energy |
- |
Completion of $5.4M Placement
|
30 Jul 2026 10:03AM |
$0.035 |
$0.039 |
risen by
10%
|
|
KKO - Price-sensitive ASX Announcement
Full Release
Key Points
- Kinetiko Energy Ltd completed a $5.4M placement.
- The placement price was $0.03 per share, a 14% discount.
- Major shareholder Talent 10 Holdings committed $3M.
- Funds will support Phase 1 development and exploration.
- The placement was structured in two tranches, pending shareholder approval.
- Tranche 1 involves 50 million shares, Tranche 2 involves 130 million shares.
- Funds will assist in developing the Brakfontein gas wells aiming for commercial production in 2027.
- Kinetiko plans to secure a new CEO and focus on gas production permitting.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Beetaloo Energy Australia Limited (BTL) ORDINARY FULLY PAID |
Energy |
$354 |
BTL Signs Digital Development MOU with Halliburton
|
30 Jul 2026 10:03AM |
$0.220 |
$0.235 |
risen by
6.82%
|
|
| Kingsland Minerals Ltd (KNG) ORDINARY FULLY PAID |
Materials |
$6 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jul 2026 10:03AM |
$0.069 |
$0.062 |
fallen by
10.14%
|
|
KNG - Price-sensitive ASX Announcement
Full Release
Key Points
- Completed soil sampling at Lake Johnston confirming lithium anomalies.
- High gallium recovery rate at Leliyn Graphite Project.
- Received R&D tax refund of $809,000 post-quarter end.
- End of quarter cash balance at $458,000.
- Continued focus on exploration in Northern Territory and Western Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mesoblast Limited (MSB) ORDINARY FULLY PAID |
Health Care |
$3,117 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jul 2026 10:01AM |
$2.010 |
$2.400 |
risen by
19.40%
|
|
MSB - Price-sensitive ASX Announcement
Full Release
Key Points
- Ryoncil® net revenue was US$36 million for the quarter.
- Full-year Ryoncil® revenue was US$115 million.
- Net operating cash spend was US$43.8 million for the full year.
- US$103 million of cash held at June 30, 2026.
- Drew US$50 million from a five-year facility to clear debts.
- Expanding Ryoncil® use to adults with SR-aGvHD.
- Achieved target of 300 patients treated in a Phase 3 trial for chronic low back pain.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EQ Resources Limited (EQR) ORDINARY FULLY PAID |
Materials |
$1,650 |
Cleansing Notice
|
30 Jul 2026 10:00AM |
$0.260 |
$0.320 |
risen by
23.08%
|
|
| Environmental Clean Technologies Limited (ECT) ORDINARY FULLY PAID |
Industrials |
$45 |
Continuation of Suspension from Quotation
|
30 Jul 2026 10:00AM |
$0.135 |
$0.125 |
fallen by
7.41%
|
|
ECT - Price-sensitive ASX Announcement
Full Release
Key Points
- Environmental Clean Technologies Limited (ASX: ECT) has been suspended from quotation.
- The suspension was requested by ECT pending an announcement regarding a potential acquisition and an ASX price query response.
- Voluntary suspension was initially granted until 30 July 2026.
- As of 30 July 2026, ECT is not ready to release an announcement that would enable reinstatement of its securities.
- Securities remain suspended in accordance with Listing Rule 17.3.
- Suspension continues until ASX is satisfied with ECT's compliance with Listing Rules, including Listing Rule 3.1.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EQ Resources Limited (EQR) ORDINARY FULLY PAID |
Materials |
$1,650 |
Application for quotation of securities - EQR
|
30 Jul 2026 10:00AM |
$0.260 |
$0.320 |
risen by
23.08%
|
|
| Alterity Therapeutics Limited (ATH) ORDINARY FULLY PAID |
Health Care |
$122 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jul 2026 10:00AM |
$0.510 |
$0.560 |
risen by
9.80%
|
|
ATH - Price-sensitive ASX Announcement
Full Release
Key Points
- Positive FDA End-of-Phase 2 meeting for ATH434.
- Planned initiation of Phase 3 trial by end of 2026.
- Received A$3.98 million R&D Tax Incentive refund.
- Cash balance of A$37.3 million as of June 30, 2026.
- Strategic funding and partnership evaluations ongoing.
- Ms Ann Cunningham appointed to Board of Directors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| OD6 Metals Limited (OD6) ORDINARY FULLY PAID |
Materials |
$38 |
Investor Briefing Webinar - Amended
|
30 Jul 2026 9:59AM |
$0.105 |
$0.130 |
risen by
23.81%
|
|
| Lincoln Minerals Limited (LML) ORDINARY FULLY PAID |
Materials |
$23 |
Proposed issue of securities - LML
|
30 Jul 2026 9:59AM |
$0.012 |
$0.008 |
fallen by
33.33%
|
|
| SRG Global Limited (SRG) ORDINARY FULLY PAID |
Industrials |
$2,193 |
Advance Notice - Full Year Results Investor Briefing
|
30 Jul 2026 9:59AM |
$3.340 |
$3.500 |
risen by
4.79%
|
|
| Aguia Resources Limited (AGR) ORDINARY FULLY PAID |
Materials |
$41 |
Cleansing Notice
|
30 Jul 2026 9:59AM |
$0.016 |
$0.017 |
risen by
6.25%
|
|
| RAS Technology Holdings Limited (RTH) ORDINARY FULLY PAID |
Industrials |
$34 |
Tabcorp signs new agreement for Data and Content
|
30 Jul 2026 9:58AM |
$0.580 |
$0.700 |
risen by
20.69%
|
|
RTH - Price-sensitive ASX Announcement
Full Release
Key Points
- Tabcorp signs new four-year agreement with RAS Technology Holdings Limited to provide domestic data and content.
- Contract value over the term is $9.1 million plus indexation.
- The agreement expands to include RAS's Fast Form service.
- RAS supplies market-leading data, analytics, and predictive models to Tabcorp.
- RAS and Tabcorp have a relationship spanning over 15 years.
- Either party can terminate the agreement on specific conditions with a 30-day notice.
- RAS retains the right to license the same data to other parties.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Boab Metals Limited (BML) ORDINARY FULLY PAID |
Materials |
$281 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jul 2026 9:58AM |
$0.400 |
$0.485 |
risen by
21.25%
|
|
BML - Price-sensitive ASX Announcement
Full Release
Key Points
- Boab Metals Limited executed an EPC contract with GR Engineering for relocating the DeGrussa Processing Plant to Sorby Hills.
- The contract for the plant is valued at $109 million.
- Acquisition of DeGrussa Processing Plant from Sandfire was completed.
- A six-year Diesel Supply Agreement was secured with CGL Fuel Pty Ltd.
- Site access and early works were completed within budget.
- First concentrate production is scheduled for the second half of 2027.
- A syndicated facility agreement of A$236 million in debt facilities was finalized.
- Phase IX drilling program commenced to enhance resource conversion and exploration.
- Boab Metals held a cash balance of A$60.2 million as of 30 June 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PTR Minerals Ltd (PTR) ORDINARY FULLY PAID |
Materials |
$42 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jul 2026 9:58AM |
$0.081 |
$0.105 |
risen by
29.63%
|
|
PTR - Price-sensitive ASX Announcement
Full Release
Key Points
- Maiden Mineral Resource Estimate announced for the Rosewood Titanium Project.
- Rosewood Deposit contains 463Mt at 8.8% heavy minerals.
- Net cash outflow was $484,000 from operating activities.
- Investing activities resulted in $12,078,000 net cash outflow.
- Cash and equivalents total $2.61 million; term deposits of $11.01 million.
- PTR does not plan to raise additional cash.
- Financial resources ensure continued operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vintage Energy Ltd (VEN) ORDINARY FULLY PAID |
Energy |
$5 |
FY26 Q4 Quarterly Report & Appendix 5B
|
30 Jul 2026 9:57AM |
$0.002 |
$0.002 |
fallen by
0%
|
|
VEN - Price-sensitive ASX Announcement
Full Release
Key Points
- Sales revenue for the quarter was $0.6 million, down 20% from the previous quarter.
- Production for the period was 0.05 PJe.
- The company received $5 million in South Australian government grants for the Southern Flank Joint Ventures.
- An Entitlement Offer was closed, raising $1.35 million.
- Heads of Agreement was made with Vault Energy for Cullen gas.
- Unrestricted cash at the end of the quarter stood at $1.34 million.
- No lost time injuries were recorded.
- Net cash from operating activities was reported as $2.264 million for the current quarter.
- The Odin gas field was highlighted for its strategic location and ongoing appraisal production.
- The company focuses on securing funding and commercial agreements to leverage its assets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cann Group Limited (CAN) ORDINARY FULLY PAID |
Health Care |
$6 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jul 2026 9:57AM |
$0.003 |
$0.004 |
risen by
16.67%
|
|
CAN - Price-sensitive ASX Announcement
Full Release
Key Points
- Operating cash inflow of $0.24M in June quarter.
- B2B momentum maintained, with continued deliveries.
- Exploration of strategic partnerships and M&A opportunities.
- Leadership transition with Mike Ryan as interim Executive Chairman.
- European export expansion with German export pathway.
- Successful redemption of convertible notes, simplifying capital structure.
- Secured additional $2 million private credit facility.
- Mallee Bloom launched with new SKUs.
- Improved financial performance nearing cash flow break-even.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BETR Entertainment Limited (BBT) ORDINARY FULLY PAID |
Consumer Discretionary |
$194 |
Q4 FY26 Quarterly Activities Report & Appendix 4C
|
30 Jul 2026 9:57AM |
$0.165 |
$0.185 |
risen by
12.12%
|
|
BBT - Price-sensitive ASX Announcement
Full Release
Key Points
- Positive operating cash flow of $2.6 million in Q4 FY26.
- Net win margin increased to 10.9%.
- Strong revenue growth with improved customer engagement.
- Launch of innovative SGM and racing products.
- Net cash from operating activities was $2.6 million.
- Invested $3.2 million in new products and platform development.
- Closing cash balance of $27.8 million.
- Strategic growth anticipated in FY27 with a focus on organic expansion and selective investments.
- Tasmanian gaming license secured for regulatory certainty.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| American Rare Earths Limited (ARR) ORDINARY FULLY PAID |
Materials |
$207 |
ARR advances NASDQ listing strategy
|
30 Jul 2026 9:57AM |
$0.340 |
$0.355 |
risen by
4.41%
|
|
Call 1300 880 160
Start a chat
Schedule a call
